A Phase II Clinical Study of Fruquintinib Combined With S-1 for Advanced Esophageal Squamous Cell Carcinoma
Clinical trial NCT05636150 · UNKNOWN
Trial details
- NCT number
- NCT05636150
- Sponsor
- Peking Union Medical College Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-30
- Primary completion
- 2024-03-30
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.